CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Morcher iris diaphragm implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00812708
NCT00812708N/ACompleted
CompareCT.gov

Clinical Evaluation of Morcher Artificial Iris Diaphragms to Treat Light and Glare Sensitivity in Partial or Complete Aniridia

University of California, Los Angeles·interventional·Posted Dec 22, 2008·Updated Dec 15, 2021

In Brief

A clinical study evaluating Morcher iris diaphragm implantation for Aniridia and Iris; Deformity. Completed, enrolled 72 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the safety and efficacy of Morcher iris diaphragms in the treatment of congenital and acquired aniridia. Morcher iris diaphragms are intraocular devices that are designed to provide an artificial pupil for patients suffering from partial or complete aniridia. These devices are constructed from clinical quality, ultraviolet light-absorbing, opaque black polymethylmethacrylate (PMMA). After surgical implantation, patients are monitored over the course of 1 year to measure any changes to visual acuity and improvements in light and glare sensitivity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAniridia, Iris; Deformity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 22, 2008
Enrollment StartApr 9, 2003
Primary CompletionJun 20, 2014
Study CompletionDec 7, 2021
TodayJul 2, 2026
Enrollment to primary: 11.2 yearsPosted 17.5 years ago

Interventions

Morcher iris diaphragm implantationdevice

Surgical implantation of Morcher iris device(s)